Electronic Cigarette Use Clinical Trial
Official title:
Nicotine Influence on Vascularization and Retinal Metabolism Following Electronic Cigarette Use
The marketing of electronic cigarettes (e-cigarettes) in 2003 was initially intended to present a healthier alternative to smokers. Subsequently, it became an extremely widespread fashion phenomenon, especially among young people. It thus contributes to attracting new consumers thanks to its modern and technological presentation, combined with a panoply of captivating fragrances. In 2014, the FDA still does not recognize this practice as a substitute for smoking intended to limit it, and several recent studies have demonstrated the potential harmful effects of e-cigarettes on health. Indeed, the latter also have pulmonary effects reminiscent of those of the original cigarette, namely breathing difficulties or even lung inflammation. In addition, a potential impact on the vascular system has recently been highlighted by the use of these e-cigarettes. Thus, their components can lead to vascular changes in the reactivity of blood vessels, an increase in blood pressure or even endothelial dysfunction and vascular and cerebral oxidative stress. The aim of this study is to detect these phenomena at the level of the retinal circulation, window of the central nervous system, in order to be able to confirm the acute vascular impacts of the use of an e-cigarette. In addition, the vascular and metabolic impacts due to the potential toxicity of the other components of these e-cigarettes could be investigated. Finally, the comparison between patients who are smokers and occasional smokers will provide a better understanding of the different acute and chronic effects of nicotine.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04123041 -
Characterize the Nicotine Uptake and Subjective Effects With Use of JUUL Electronic Nicotine Delivery Systems
|
N/A | |
Completed |
NCT04107779 -
Changes in Biomarkers of Cigarette Smoke Exposure After Switching Either Exclusively or Partly to JUUL ENDS
|
N/A | |
Completed |
NCT04620616 -
Nicotine Uptake, Measures of Abuse Liability, and Puffing Topography With Use of RELX ENDS Products by ENDS Consumers
|
N/A | |
Recruiting |
NCT05306158 -
Dual Use Approach Bias Training for Nicotine Addiction
|
N/A | |
Completed |
NCT04143256 -
Evaluating Selected Constituents in the Exhaled Breath Samples
|
N/A | |
Completed |
NCT04088175 -
Study to Characterize Puffing Topography With Use of JUUL Electronic Nicotine Delivery Systems (ENDS) in Adult, Closed-System ENDS Consumers
|
N/A | |
Completed |
NCT04708106 -
Characterization of Product Use in Smokers Switching From Cigarettes to a RELX Electronic Nicotine Delivery System
|
N/A | |
Recruiting |
NCT06291597 -
Vaping Adverse Lung and Heart Events Cohort
|
||
Completed |
NCT05134415 -
Use Behavior, Nicotine Uptake, and Subjective Effects Comparison of Tobacco and Menthol e-Liquids by ENDS Consumers
|
N/A | |
Completed |
NCT04640285 -
Nicotine Uptake, Measures of Abuse Liability, and Puffing Topography With Use of RELX ENDS Products by Smokers
|
N/A | |
Recruiting |
NCT05316727 -
Electronic Nicotine Delivery Devices and Potential Progression to Acute Lung Injury
|
||
Completed |
NCT04192032 -
Assessing the Effect of Flavor on ENDS Users' Experiences and Exposures
|
N/A | |
Recruiting |
NCT05278065 -
E-cigarettes for Harm Reduction in Adults With Asthma
|
N/A | |
Recruiting |
NCT05206435 -
Methadone-Maintained Smokers Switching to E-Cigarettes
|
Phase 4 | |
Completed |
NCT04316234 -
Acute Health Effects of Passive Vape Among COPD Patients
|
N/A | |
Completed |
NCT04450537 -
PACE Vape Messaging Study
|
N/A | |
Recruiting |
NCT05338801 -
Effect of Menthol on ENDS Users' Addiction and Exposure
|
N/A | |
Recruiting |
NCT05423340 -
Effect of E-Liquid Flavor on Respiratory Symptoms in People Using Electronic Nicotine Delivery Systems
|
N/A | |
Terminated |
NCT03974152 -
Effects of Nicotine Salt Aerosol on Cigarette Smokers
|
N/A | |
Not yet recruiting |
NCT06063421 -
Comparison of Nicotine Replacement Therapy and Electronic Cigarettes for Smoking Cessation in Pakistan
|
N/A |